The introduction of the 750mcg PTH injection in Australia has encountered restricted distribution . Currently, this larger dose injection is mainly intended for individuals with significant osteoporosis who have been unsuccessful with other therapies . Procurement can be complex due to specialist prescription stipulations and controlled dispensary